QUANTUM X LABS INC.
QXLNasdaqTechnology · Services-Prepackaged Software · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | $26.9M | $79.6M | $96.6M | $45.2M | $96,000 |
| Operating income | −$2.2M | −$837,000 | −$7.5M | $2.7M | $541,000 | −$454,000 |
| Net income | −$19.3M | −$12.1M | −$7.3M | $28,000 | $300,000 | −$443,000 |
| Total assets | $10.8M | $22.0M | $43.3M | $63.7M | $51.3M | $225,000 |
| Total liabilities | — | — | — | — | — | — |
| Equity | $5.0M | $5.8M | $14.8M | $22.0M | $13.7M | −$2.1M |
| EPS (diluted) | $2.28 | $2.69 | $1.97 | $0.00 | $0.02 | — |
| Shares out. | 5.3M | 14.9M | 14.8M | 34.8M | 34.8M | 31.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −386.6%
- Return on assets
- −179.3%
- Return on capital (ROCE)
- −32.6%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.94
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −153.5%clean
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 1 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 12, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2022
- NT 10-Qmissed a reporting deadline ↗May 15, 2018
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- L.I.A. Pure Capital LtdPassive (13G)May 15, 2026
- Capitalink Ltd.Passive (13G)May 15, 2026
- Daniel NissimPassive (13G)May 15, 2026
- Mmcap International Inc. SpcPassive (13G)Aug 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Yoresh EliyahuDirector | May 31, 2026 | Option exercise | 88,675 | $0.00 |
| Baranes YakovOfficer — Co-CEO | May 31, 2026 | Option exercise | 246,387 | $0.00 |
| Weiss AmitayDirector | Mar 31, 2026 | Sell | 30,296 | $2.00 |
| Yoresh EliyahuDirector | Mar 4, 2026 | Buy | 179,159 | — |
| Yoresh EliyahuDirector | Sep 3, 2025 | Buy | 260,000 | $1.00 |
| Yoresh EliyahuDirector | Jun 17, 2025 | Gift | 405 | $0.00 |
| Yoresh EliyahuDirector | Jun 18, 2024 | Buy | 2,518 | $1.00 |
| Marom ShaharOfficer — Chief Financial Officer | Jun 18, 2024 | Buy | 1,259 | $1.00 |
| Weiss AmitayDirector | Jun 18, 2024 | Buy | 2,518 | $1.00 |
| Baumann YoramDirector | Jun 18, 2024 | Buy | 9,444 | $1.00 |
| Hadad AmihayOfficer — Chief Executive Officer | Jun 18, 2024 | Buy | 2,518 | $1.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7,477 | 1.0 | -48.2% |
| Apr 30, 2026 | 14,427 | 1.0 | -60.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 29, 2026
- Director / officer changeMay 15, 2026
- Other material eventMay 14, 2026
- Amended charter or bylaws · Regulation FD disclosure · Other material eventApr 30, 2026
- Regulation FD disclosure · Other material eventApr 21, 2026
- Entered a material agreement · Unregistered equity saleJan 2, 2026
- Entered a material agreement · Unregistered equity saleDec 15, 2025
- Other material eventNov 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4Jun 1, 2026
- 3Jun 1, 2026
- 4Jun 1, 2026
- 3Jun 1, 2026
- 3Jun 1, 2026
- 8-KMay 29, 2026
- 8-KMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- 10-QMay 14, 2026
- 8-KMay 14, 2026
- 8-KApr 30, 2026
- 8-KApr 21, 2026
- RWApr 14, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.